zonisamide has been researched along with Myelopathy in 2 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Degenerative cervical myelopathy (DCM) is a severe condition of the spinal cord caused by chronic compression." | 5.91 | Zonisamide improves Fas/FasL-mediated apoptosis and inflammation in a degenerative cervical myelopathy rat model. ( Tan, Y; Wang, Z; Xu, F, 2023) |
| "Cervical spondylotic myelopathy (CSM) is caused by chronic compression of the spinal cord and is the most common cause of myelopathy in adults." | 5.56 | Zonisamide ameliorates progression of cervical spondylotic myelopathy in a rat model. ( Imagama, S; Inoue, T; Ishiguro, N; Ito, M; Kanbara, S; Koshimizu, H; Masuda, A; Nakashima, H; Ohkawara, B; Ohno, K; Ohta, K; Tomita, H, 2020) |
| "Degenerative cervical myelopathy (DCM) is a severe condition of the spinal cord caused by chronic compression." | 1.91 | Zonisamide improves Fas/FasL-mediated apoptosis and inflammation in a degenerative cervical myelopathy rat model. ( Tan, Y; Wang, Z; Xu, F, 2023) |
| "Cervical spondylotic myelopathy (CSM) is caused by chronic compression of the spinal cord and is the most common cause of myelopathy in adults." | 1.56 | Zonisamide ameliorates progression of cervical spondylotic myelopathy in a rat model. ( Imagama, S; Inoue, T; Ishiguro, N; Ito, M; Kanbara, S; Koshimizu, H; Masuda, A; Nakashima, H; Ohkawara, B; Ohno, K; Ohta, K; Tomita, H, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 1 |
| Tan, Y | 1 |
| Xu, F | 1 |
| Kanbara, S | 1 |
| Ohkawara, B | 1 |
| Nakashima, H | 1 |
| Ohta, K | 1 |
| Koshimizu, H | 1 |
| Inoue, T | 1 |
| Tomita, H | 1 |
| Ito, M | 1 |
| Masuda, A | 1 |
| Ishiguro, N | 1 |
| Imagama, S | 1 |
| Ohno, K | 1 |
2 other studies available for zonisamide and Myelopathy
| Article | Year |
|---|---|
Zonisamide improves Fas/FasL-mediated apoptosis and inflammation in a degenerative cervical myelopathy rat model.
Topics: Animals; Apoptosis; Caspase 10; Caspase 3; Caspase 8; Caspase 9; Fas Ligand Protein; Inflammation; P | 2023 |
Zonisamide ameliorates progression of cervical spondylotic myelopathy in a rat model.
Topics: Animals; Cervical Vertebrae; Disease Models, Animal; Disease Progression; Female; Motor Neurons; Rat | 2020 |